Halogenated benzoxazines and their use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9796730
SERIAL NO

14632534

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel halogenated benzoxazines, methods for their production, their use for the diagnosis of diseases and their use for the production of medicaments for the diagnosis of diseases, preferably dementia diseases and in particular the Alzheimer's disease, in humans and/or animals.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAETTUEBINGEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kesenheimer, Christian Dusslingen, DE 2 2
Maier, Florian Reutlingen-Oststadt, DE 48 105
Pichler, Bernd Scheyern, DE 7 19
Stumm, Ramona Sonnenbuehl, DE 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 24, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 24, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00